Home › Funds › 325 CAPITAL LLC › LFCR
325 CAPITAL LLC position in LFCR
LIFECORE BIOMEDICAL INC · Health Care
325 CAPITAL LLC reported holding 2,895,881 shares of LFCR (LIFECORE BIOMEDICAL INC) in its Q2 2026 13F filing — a position valued at US$15.2M, representing 3.62% of its reported portfolio and ranking #9 among its reported holdings. 325 CAPITAL LLC has disclosed LFCR holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How 325 CAPITAL LLC's LFCR position evolved
325 CAPITAL LLC first disclosed a stake in LFCR in Q4 2023 at 1,206,969 shares (US$7.5M). The position peaked in Q4 2025 at 2,162,466 shares, worth US$17.7M. Across 11 filings, 325 CAPITAL LLC increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 2,895,881 shares valued at US$15.2M — an increase of 733,415 shares quarter over quarter.. Notable position changes include a 58% increase in Q4 2024 (shares fell 5% over the following quarter), a 34% increase in Q2 2026 (shares rose 25% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 1.21M | $7.47M | New |
| Q1 2024 | 1.34M | $7.12M | Add |
| Q2 2024 | 1.34M | $6.88M | Hold |
| Q3 2024 | 1.37M | $6.75M | Add |
| Q4 2024 | 2.16M | $16.07M | Add |
| Q1 2025 | 2.16M | $15.22M | Hold |
| Q2 2025 | 2.16M | $17.56M | Hold |
| Q3 2025 | 2.16M | $15.92M | Hold |
| Q4 2025 | 2.16M | $17.69M | Hold |
| Q1 2026 | 2.16M | $8.04M | Hold |
| Q2 2026 | 2.90M | $15.20M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LFCR and 13F data
LFCR (LIFECORE BIOMEDICAL INC) is a Health Care company. 21 other funds we track also report a position in LFCR — the largest reported positions include WYNNEFIELD CAPITAL INC (US$24.7M), Legion Partners Asset Management, LLC (US$23.4M), Greenhaven Road Investment Management, L.P. (US$16.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LFCR
- WYNNEFIELD CAPITAL INC 4.70M sh · $24.69M · Q2 2026
- Legion Partners Asset Management, LLC 4.46M sh · $23.42M · Q2 2026
- Greenhaven Road Investment Management, L.P. 3.19M sh · $16.75M · Q2 2026
- DCF Advisers, LLC 424.50K sh · $2.23M · Q2 2026
- WITTENBERG INVESTMENT MANAGEMENT, INC. 314.01K sh · $1.65M · Q2 2026
More on 325 CAPITAL LLC
FAQ
How long has 325 CAPITAL LLC held LFCR?
325 CAPITAL LLC has disclosed LFCR holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
What is 325 CAPITAL LLC's current position in LFCR?
As of Q2 2026, 325 CAPITAL LLC holds 2.90M shares of LFCR (LIFECORE BIOMEDICAL INC), valued at $15.20M, representing 3.62% of its reported portfolio and ranking #9.
Has 325 CAPITAL LLC been buying or selling LFCR?
In the latest 13F filing (Q2 2026), 325 CAPITAL LLC increased its position in LFCR. The position peaked in Q4 2025 at 2.16M shares.
Which other funds hold LFCR?
Other major institutional holders of LFCR include WYNNEFIELD CAPITAL INC, Legion Partners Asset Management, LLC, Greenhaven Road Investment Management, L.P., among 21 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.